Back
Speaker illustration

Doctor Ola Vedin

Uppsala University Hospital, Uppsala (Sweden)

Presentations

Early real-world implementation of sacubitril/valsartan in Sweden

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Access
Like
Thumbnail

Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography

Access
Like
Thumbnail

Significance of ischemic heart disease in patients with heart failure with preserved, mid-range and reduced ejection fraction - A nationwide cohort study

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Chronic pulmonary hypertension

Session: Rapid Fire 4 - Therapy and management

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources